.jpg)
- Clinical drug investigation
-
影響因子：
1.915
-
I S S N：
1173-2563
-
出 版 社：
Adis International
-
出 版 地：
Mairangi Bay, Auckland, N.Z., Philadelphia
-
出版國(guó)家：
New Zealand
-
刊 期：
月刊
-
創(chuàng)刊時(shí)間：
1995
-
語(yǔ) 種：
英文
-
審稿周期：
較慢,6-12周
-
中科院分區(qū)：
4
-
投稿命中率：
較易
-
國(guó)外數(shù)據(jù)庫(kù)收錄：
IM
-
中國(guó)收錄文章數(shù)：
23
-
5年影響因子：
1.639
-
研究領(lǐng)域：
臨床試驗(yàn)專(zhuān)題、藥物評(píng)價(jià)、藥物治療、藥物研究、研究性新藥申請(qǐng)、藥物制劑
-
官方鏈接：
http://link.springer.com/journal/40261
-
投稿須知：
http://link.springer.com/journal/40261
期刊介紹：
Clinical Drug Investigation gives you rapid access to the best designed, peer reviewed clinical and pharmacoeconomic studies worldwide, allowing you to keep up to date with the latest original research in this exciting area. The Journal's aim is rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. This includes clinical trials, outcomes research, clinical pharmacoeconomic studies, pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs, clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice and, in some instances, pharmacodynamic or pharmacokinetic studies in healthy volunteers, but in which some established or purported implications for clinical prescribing are discussed. In addition, short communications and case study reports that meet these criteria are also encouraged, as are letters to the editor.
